Caisse Des Depots ET Consignations Makes New Investment in Kenvue Inc. (NYSE:KVUE)

Caisse Des Depots ET Consignations acquired a new stake in Kenvue Inc. (NYSE:KVUE) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 233,185 shares of the company’s stock, valued at approximately $4,978,000.

Several other institutional investors have also recently added to or reduced their stakes in KVUE. State Street Corp lifted its position in shares of Kenvue by 16.8% during the 3rd quarter. State Street Corp now owns 127,213,940 shares of the company’s stock worth $2,942,458,000 after buying an additional 18,283,473 shares during the last quarter. Boston Partners lifted its position in Kenvue by 36.9% in the fourth quarter. Boston Partners now owns 23,595,963 shares of the company’s stock valued at $503,145,000 after acquiring an additional 6,366,097 shares during the last quarter. Holocene Advisors LP boosted its stake in Kenvue by 75.5% in the third quarter. Holocene Advisors LP now owns 13,886,454 shares of the company’s stock valued at $321,194,000 after acquiring an additional 5,975,392 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Kenvue during the fourth quarter worth about $98,926,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Kenvue by 30.2% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 9,992,933 shares of the company’s stock worth $231,137,000 after purchasing an additional 2,316,443 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on KVUE. Piper Sandler increased their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Monday, February 24th. Evercore ISI initiated coverage on Kenvue in a research note on Monday. They set an “in-line” rating and a $25.00 target price for the company. UBS Group cut their target price on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, February 7th. Citigroup lowered their price target on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 15th. Finally, Canaccord Genuity Group lifted their price target on shares of Kenvue from $24.00 to $29.00 and gave the stock a “buy” rating in a report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $23.85.

Kenvue Price Performance

Kenvue stock opened at $23.40 on Thursday. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The business’s 50-day simple moving average is $22.22 and its 200 day simple moving average is $22.45. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The stock has a market cap of $44.72 billion, a price-to-earnings ratio of 44.15, a P/E/G ratio of 2.62 and a beta of 1.25.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were paid a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date was Wednesday, February 12th. Kenvue’s payout ratio is 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.